Skip to main content

2 Result(s)

within S. Isfort Remove this filter

and

  1. No Access

    Article

    Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians

    Philadelphia-negative myeloproliferative neoplasms (MPN) comprise a heterogeneous group of chronic hematological malignancies with significant variations in clinical characteristics. Due to the long survival a...

    A. Kaifie, S. Isfort, N. Gattermann, W. Hollburg, M. Klausmann… in Annals of Hematology (2016)

  2. Article

    Open Access

    Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

    Patients with Ph-negative myeloproliferative neoplasms (MPN), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at increased risk for thrombosis/thromboemboli...

    A. Kaifie, M. Kirschner, D. Wolf, C. Maintz, M. Hänel… in Journal of Hematology & Oncology (2016)

    Download PDF (593 KB) View Article